Skip to content
DraconiticResearch
Search Sources API
203,234 studies31 sourcesUpdated 17 min ago
Peer-reviewedCC BY-NC-NDTranslational andrology and urology

Testicular microcirculation dysfunction-induced Sertoli cell injury-exosome therapy as a novel restorative strategy: a narrative review.

  1. 1The Second Clinical Medical College of Henan University of Chinese Medicine, Zhengzhou, China.
  2. 2Henan Province Hospital of Traditional Chinese Medicine (The Second Affiliated Hospital of Henan University of Chinese Medicine), Zhengzhou, China.

Abstract

Testicular microcirculation disorders, arising from systemic or local factors, have increasingly been recognized for their detrimental impact on male reproductive health. Sertoli cells are essential for maintaining the spermatogenic microenvironment, constructing the blood-testis barrier, and supporting spermatogenic cell proliferation. Dysfunction of Sertoli cells is a major contributor to testicular dysfunction and male infertility. This review aims to elucidate how testicular microcirculation disorders impair Sertoli cell function and to explore the potential of exosome-based therapies in restoring Sertoli cell function. A narrative literature search of PubMed and Web of Science was conducted up to August 25, 2026, to identify relevant publications on testicular microcirculation, Sertoli cell dysfunction, and exosome-based therapeutic strategies. Selected articles were reviewed and synthesized narratively. Testicular microcirculation disorders impair Sertoli cell function primarily through oxidative stress, disruption of the internal microenvironment, and endocrine/paracrine imbalances. These pathological processes collectively damage male reproductive health. In recent years, exosome-based technologies have shown significant promise in restoring Sertoli cell function. Specifically, exosomes derived from Sertoli cells or mesenchymal stem cells can protect and enhance Sertoli cell function by mediating intercellular communication and delivering bioactive molecules. This review provides an in-depth analysis of the mechanisms linking testicular microcirculation disorders to Sertoli cell dysfunction and highlights the therapeutic potential of exosome technologies. These findings offer new insights and approaches for the treatment and prevention of male reproductive impairment.

Related

  1. Beyond Recurrence: Impact of Surgical Technique on Testicular Microcirculation After Inguinal Hernia Repair.
    Mehmet Emin Gönüllü, Fatih Gürsoy, İbrahim Feyyaz Naldemir +3
    BMC surgeryPeer-reviewedCC BY-NC-NDFull textSurgery & anaesthesiaEurope PMCDOAJ
  2. Cognitive–emotional associations between non-restorative sleep and erectile dysfunction: the role of rumination profiles and resilience
    Sexual medicinePeer-reviewedCC BY-NCFull textGeneral medicineEurope PMC
  3. Assessment of nailfold microcirculation in non-dialysis CKD: Capillaroscopic indicators correlated with renal dysfunction
    Shulin Li, Ying Liu, Han Yan +5
    PLOS OnePeer-reviewedCC BY 4.0Full textPhysiologyPLOS
  4. G-quadruplex targeting by CX-5461 as a novel therapeutic strategy in testicular germ cell tumors
    R. Islam, A. Liesen, C. S. R. Roque +2
    bioRxivPreprintCC BY-NCFull textOncologybioRxiv
  5. An intrascrotal bioadhesive nanoplatform for sustained hydrogen delivery ameliorates age-associated testicular dysfunction.
    Shu Liang, Jiawei Lv, Zun Li +7
    Materials today. BioPeer-reviewedCC BY-NCFull textSurgery & anaesthesiaEurope PMC
BibTeX
@article{lin2026testicular,
  title = {{Testicular microcirculation dysfunction-induced Sertoli cell injury-exosome therapy as a novel restorative strategy: a narrative review.}},
  author = {Shukun Lin and Jianshe Chen and Bo Men and Zhixu Chen},
  journal = {Translational andrology and urology},
  year = {2026},
  month = sep,
  doi = {10.21037/tau-2026-0660},
  url = {https://europepmc.org/article/MED/42997181},
  note = {CC BY-NC-ND},
}
RIS
TY  - JOUR
TI  - Testicular microcirculation dysfunction-induced Sertoli cell injury-exosome therapy as a novel restorative strategy: a narrative review.
AU  - Shukun Lin
AU  - Jianshe Chen
AU  - Bo Men
AU  - Zhixu Chen
PY  - 2026
DA  - 2026/09/29
JO  - Translational andrology and urology
DO  - 10.21037/tau-2026-0660
UR  - https://europepmc.org/article/MED/42997181
AB  - Testicular microcirculation disorders, arising from systemic or local factors, have increasingly been recognized for their detrimental impact on male reproductive health. Sertoli cells are essential for maintaining the spermatogenic microenvironment, constructing the blood-testis barrier, and supporting spermatogenic cell proliferation. Dysfunction of Sertoli cells is a major contributor to testicular dysfunction and male infertility. This review aims to elucidate how testicular microcirculation disorders impair Sertoli cell function and to explore the potential of exosome-based therapies in restoring Sertoli cell function. A narrative literature search of PubMed and Web of Science was conducted up to August 25, 2026, to identify relevant publications on testicular microcirculation, Sertoli cell dysfunction, and exosome-based therapeutic strategies. Selected articles were reviewed and synthesized narratively. Testicular microcirculation disorders impair Sertoli cell function primarily through oxidative stress, disruption of the internal microenvironment, and endocrine/paracrine imbalances. These pathological processes collectively damage male reproductive health. In recent years, exosome-based technologies have shown significant promise in restoring Sertoli cell function. Specifically, exosomes derived from Sertoli cells or mesenchymal stem cells can protect and enhance Sertoli cell function by mediating intercellular communication and delivering bioactive molecules. This review provides an in-depth analysis of the mechanisms linking testicular microcirculation disorders to Sertoli cell dysfunction and highlights the therapeutic potential of exosome technologies. These findings offer new insights and approaches for the treatment and prevention of male reproductive impairment.
SN  - 2223-4691
ER  -